FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
UNITED BANKSHARES INC/WV [ UBSI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 02/22/2021 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 02/22/2021 | A | 3,644(1) | A | $0.0000 | 27,611.584(2) | D | |||
Common Stock | 02/22/2021 | A | 3,231(3) | A | $0.0000 | 30,842.584(2) | D | |||
Common Stock | 4,641.352 | I(4) | By 401k | |||||||
Common Stock | 79 | I | By Spouse |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option | $32.51 | 02/22/2021 | A | 3,647(5) | 02/24/2021 | 02/24/2030 | Common Stock | 3,647 | $0.0000 | 3,647 | D | ||||
Stock Option | $26.19 | 02/19/2013 | 02/19/2023 | Common Stock | 2,250 | 2,250 | D | ||||||||
Stock Option | $28.89 | 02/24/2014 | 02/24/2024 | Common Stock | 2,500 | 2,500 | D | ||||||||
Stock Option | $29.4 | 02/28/2012 | 02/28/2022 | Common Stock | 2,250 | 2,250 | D | ||||||||
Stock Option | $32.51 | 02/24/2020 | 02/24/2030 | Common Stock | 7,295 | 7,295 | D | ||||||||
Stock Option | $35.04 | 02/29/2016 | 02/28/2026 | Common Stock | 5,000 | 5,000 | D | ||||||||
Stock Option | $36.92 | 02/23/2015 | 02/23/2025 | Common Stock | 5,000 | 5,000 | D | ||||||||
Stock Option | $37.6 | 02/26/2018 | 02/26/2028 | Common Stock | 7,676 | 7,676 | D | ||||||||
Stock Option | $38.49 | 02/25/2019 | 02/25/2029 | Common Stock | 5,455 | 5,455 | D | ||||||||
Stock Option | $45.3 | 02/27/2017 | 02/27/2027 | Common Stock | 7,676 | 7,676 | D |
Explanation of Responses: |
1. Shares were acquired pursuant to a grant of restricted stock units. The award vests in three equal installments beginning on February 22, 2022. |
2. Additional stock acquired in the Dividend Reinvestment Plan. |
3. On February 24,2020, the reporting person was awarded shares of restricted stock that vests in four equal installments from the date of grant upon the Company satisfying certain performance criteria for the year ended 2020. The performance criteria for 2020 was met, resulting in the vesting of one-fourth of the 9,692 restricted shares which is 2,423 shares. The company voluntarily reported 6,461 shares of the 9,692 shares of restricted stock awarded as restricted stock (units) on a Form 4 filed on February 25,2020 even though the restricted shares were subject to performance criteria. |
4. Includes additional shares acquired under the UBSI 401K plan since the date of the reporting person's last 401K ownership report. |
5. On February 24,2020, the reporting person was granted options to purchase common stock that vest in four equal installments from the date of grant upon the Company's satisfaction of certain performance criteria for the year ended 2020. The performance criteria for 2020 was met resulting in the vesting of one fourth of the 10,942 options which is 2,735 stock options. The Company voluntarily reported 7,295 of stock options on a Form 4 filed on February 25, 2020 even though the stock options were subject to performance criteria. |
By: Jennie S Singer, Lmtd POA, Attorney-in-Fact | 02/24/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |